Eli Lilly & Co. (LLY)
1014.02
-10.98
(-1.07%)
USD |
NYSE |
Feb 11, 15:37
Eli Lilly Market Cap : 907.57B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 196.97B |
| Biogen, Inc. | 28.05B |
| Gilead Sciences, Inc. | 193.58B |
| Regeneron Pharmaceuticals, Inc. | 82.34B |
| Viking Therapeutics, Inc. | 3.196B |
Market Cap Related Metrics
| PE Ratio | 44.17 |
| PS Ratio | 13.99 |
| PEG Ratio | 0.4426 |
| Price to Book Value | 38.14 |
| Price | 1014.02 |
| Earnings Yield | 2.26% |
| PEGY Ratio | 0.4400 |
| Operating PE Ratio | 30.71 |
| Normalized PE Ratio | 40.26 |